Incomplete Response in Late Life Depression: Getting to Remission

Trial Profile

Incomplete Response in Late Life Depression: Getting to Remission

Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2018

At a glance

  • Drugs Aripiprazole (Primary) ; Venlafaxine (Primary)
  • Indications Depression
  • Focus Therapeutic Use
  • Acronyms IRL Grey; IRLGREY
  • Most Recent Events

    • 03 Apr 2018 Results (n=468) assessing executive function (EF) is associated with nonremission and noncompletion of antidepressant pharmacotherapy in older adults with depression, were published in the Journal of Clinical Psychiatry.
    • 09 Mar 2016 Results (N = 181) assessing predictors and moderators of remission published in the JAMA Psychiatry.
    • 28 Sep 2015 Results published in The Lancet, according to Centre for Addiction and Mental Health media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top